ReleaseWire Connect

Drug discovery services have undergone a drastic change with the advancements in modern molecular biology methods and advanced knowledge of human genome. Drug discovery is becoming more hypothesis-driven target-based approach. Pharmaceutical companies and regulatory bodies are contributing to the drug discovery. Major pharmaceutical companies are also focusing on developing the team of excellent scientists working in many therapeutic fields and technologies. In the recent years, there has been an increase in a number of approvals for first-in-class drugs, this reflects the impact of advanced drug discovery technologies, and approaches. Drug discovery service providers are also focusing on sequencing of the human genome in order to open the way to genomics-based methods in drug discovery. Innovation currently seen in the drug discovery methods is based on more information about targets, disease phenotypes, and compounds.

According to Fact.MR, the global peptide and heparin market is projected to reflect a high single-digit CAGR throughout the forecast period (2017-2026). The market is estimated to reach nearly US$ 35,000 Mn revenues by 2026-end.

Sepsis is a severe illness triggered by body's response to an infection. Factors that are resulting in the growth of sepsis diagnostics market are the rise in aging population, increasing incidences of hospital acquired infections and the growth in the development of innovative products and approvals of those products. Major market players are also increasingly investing in the research and development of new treatments, tests and interventions in order to detect, treat and prevent diseases. Depending on the symptoms, various tests are being performed including blood tests, laboratory tests, and imaging scans. Also, a lot of diagnostic tools are under the approval process and clearance by the Food and Drugs Administration (FDA).

According to Fact.MR, global emergency medical service products market is projected to register a CAGR of over 7% in terms of value over the forecast period, 2017 to 2026. Volume sales of emergency medical service products is estimated to reach roughly 99,000 units by 2026-end.

According to Fact.MR's recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-end.

Advancements in antibiotic residue diagnostics have extended their use of test kits to detect the presence of such residue in food originating from animals. The adoption of antibiotic residue test kits is gaining considerable traction as a food safety measure. Consumers are preferring products that have cleared the antibiotic residue tests, considering the role of these kits in ensuring that the food contains the essential antibiotic elements. Over the years, antibiotic residue test kits have evolved from simple diagnostic kits to multi-disciplinary tests that have incurred distinguished developments in terms of detecting the residues.

Asia-Pacific excluding Japan will also record an impressive expansion in the market through 2026, mainly driven by rising number of research grants related to sequencing projects in its developing nations such as China and India. Incorporation of high-throughput screening encouraged by positive research & development outcomes in the region will further drive the market growth in APEJ.

Fact.MR foresees that the demand for intraoperative MRI equipment will soar vigorously in the future. The report assesses that the global market for intraoperative MRI equipment will expand at a CAGR of 7.5% during the period, 2017-2026. New intraoperative MRI equipment entering the market offer real-time visualization throughout the stages of brain surgery, which is further set to bolster their demand globally in the coming years. By the end of 2026, nearly 5,500 units of intraoperative MRI equipment are likely to be sold worldwide.

Several parameters and data points are gathered and centrally managed during NICU admissions, which comprise physiological parameters, sensor readings, device data, and interventions and observations of caregivers. High data volume generated in NICUs are leveraged for predictive monitoring that involves physiological data analysis for identifying infants at high risk, thereby enabling early detection of ailments.

With growing innovations in drug delivery systems, for instance adoption of prefilled syringes, the administration of biologics has been convenient and effective. Novel drug delivery systems such as prefilled syringes have gained high traction as effective delivery systems especially for injectable drugs. Moreover, prefilled syringes are aiding in delivery of personalized drugs specifically tailored for small patient populations.